Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia

被引:38
|
作者
Goto, Y [1 ]
O'Donnell, P [1 ]
机构
[1] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA
关键词
nucleus accumbens; prefrontal cortex; hippocampus; dopamine; schizophrenia; animal model;
D O I
10.1016/S0006-3223(03)00783-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: A neonatal hippocampal lesion induces postpubertal behavioral alterations resembling phenomena observed in schizophrenia. We have recently reported that nucleus accumbens neurons exhibit altered response to ventral tegmental area activation, but only when animals with this lesion reach adulthood, Because a prefrontal cortical lesion eliminates postpubertal abnormal behaviors in these animals, we investigated whether altered accumbens responses were reversed with this manipulation. Methods: In vivo intracellular recordings were conducted in accumbens neurons in rats that had received neonatal hippocampal lesions combined with either adult prefrontal cortical lesion or sham treatment. Accumbens response to mesolimbic pathway activation was recorded in these animals. Results. Accumbens neurons from animals with a neonatal hippocampal lesion and an adult prefrontal sham operation still showed altered accumbens response to mesolimbic stimulation. On the other hand, most animals with combined neonatal hippocampal and adult prefrontal lesions exhibited responses similar to those of naive animals. Conclusions. This result suggests that abnormal behaviors in these animals might be related to excessive prefrontal drive of accumbens neurons upon dopamine activation.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [1] Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia
    Callicott, JH
    Egan, MF
    Mattay, VS
    Bertolino, A
    Bone, AD
    Verchinksi, B
    Weinberger, DR
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 709 - 719
  • [2] Changes in prefrontal dopamine function during adolescence and in a developmental animal model of schizophrenia
    O'Donnell, P
    Tseng, KY
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S68 - S69
  • [3] Altered prefrontal excitation-inhibition balance in a developmental animal model of schizophrenia
    O'Donnell, P.
    JOURNAL OF NEUROCHEMISTRY, 2012, 122 : 6 - 6
  • [4] Altered prefrontal cortical synaptic plasticity in developmental disruption animal model of schizophrenia
    Goto, Y
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 152S - 153S
  • [5] Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia
    Damgaard, Trine
    Plath, Niels
    Neill, Jo C.
    Hansen, Suzanne L.
    PSYCHOPHARMACOLOGY, 2011, 214 (02) : 403 - 413
  • [6] Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia
    Alexandra I. Zugno
    Ricardo Filipe Julião
    Josiane Budni
    Ana Maria Volpato
    Daiane B. Fraga
    Felipe D. Pacheco
    Pedro F. Deroza
    Renata D. Luca
    Mariana B. de Oliveira
    Alexandra S. Heylmann
    João Quevedo
    Metabolic Brain Disease, 2013, 28 : 501 - 508
  • [7] An atypical antipsychotic lurasidone potently reverses impairments of learning and memory in an animal model for schizophrenia
    Enomoto, T.
    Ishibashi, T.
    Tokuda, K.
    Ishiyama, T.
    Toma, S.
    Ito, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S130 - S130
  • [8] Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia
    Trine Damgaard
    Niels Plath
    Jo C. Neill
    Suzanne L. Hansen
    Psychopharmacology, 2011, 214 : 403 - 413
  • [9] Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia
    Zugno, Alexandra I.
    Juliao, Ricardo Filipe
    Budni, Josiane
    Volpato, Ana Maria
    Fraga, Daiane B.
    Pacheco, Felipe D.
    Deroza, Pedro F.
    Luca, Renata D.
    de Oliveira, Mariana B.
    Heylmann, Alexandra S.
    Quevedo, Joao
    METABOLIC BRAIN DISEASE, 2013, 28 (03) : 501 - 508
  • [10] Abnormal kainate receptor expression in prefrontal cortex in schizophrenia
    Meador-Woodruff, JH
    Davis, KL
    Haroutunian, V
    NEUROPSYCHOPHARMACOLOGY, 2001, 24 (05) : 545 - 552